PAVmed Inc.
Market Cap
$5.58M
P/E Ratio
-0.87
EPS
$-12.00
Dividend Yield
0.00%
52-Week Range
$6.00 — $28.44
Volume
7.95K
Avg Volume
1.06M
Beta
0.88
P/E (TTM)
-0.87
Forward P/E
—
PEG Ratio
-0.02
P/S (TTM)
188.89
P/B (TTM)
0.20
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
0.10%
ROA (TTM)
0.08%
ROIC
—
Gross Margin
-6.69%
Operating Margin
-696.28%
Net Margin
—
Debt/Equity
0.26
Current Ratio
0.40
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.41%
EPS Growth (5Y)
+0.20%
Sales Growth (3Y)
+1.83%
Sales Growth (5Y)
+1.10%
EPS Est (This Year)
$-24.00
EPS Est (Next Year)
$0.00
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$4.32
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
537.04K
Float
441.17K
Free Float %
82.15%
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
NASDAQ
IPO Date
2016-07-27
Employees
39
CEO
Lishan Aklog
Index Membership
—
Website
https://www.pavmed.com
PAVmed Inc. (PAVM) is a healthcare company in the medical - devices industry listed on the NASDAQ. With a market capitalization of $5.58M, a P/E ratio of -0.87, PAVM is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare PAVM against other stocks using dozens of fundamental and technical filters.
PAVmed Inc. (PAVM) has a trailing twelve-month (TTM) P/E ratio of -0.87. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, PAVmed Inc. (PAVM) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
PAVmed Inc. (PAVM) has a market capitalization of $5.58 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.